No Cover Image

Journal article 885 views 20 downloads

Compulsory licensing: an effective tool for securing access to Covid-19 vaccines for developing states?

Lowri Davies Orcid Logo

Legal Studies, Volume: 43, Issue: 1, Pages: 86 - 103

Swansea University Author: Lowri Davies Orcid Logo

  • 59971.vor.pdf

    PDF | Version of Record

    © The Author(s), 2022. Published by Cambridge University Press on behalf of The Society of Legal Scholars. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence

    Download (275.93KB)

Check full text

DOI (Published version): 10.1017/lst.2022.24

Abstract

A significant issue in combatting the Covid-19 pandemic is the need to enhance developing states’ access to Covid-19 vaccines. The present paper considers the request for a temporary waiver of intellectual property rights in relation to Covid-19 technologies and treatments submitted to the World Tra...

Full description

Published in: Legal Studies
ISSN: 0261-3875 1748-121X
Published: Cambridge University Press (CUP) 2023
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa59971
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2022-05-06T09:41:08Z
last_indexed 2023-04-18T03:18:30Z
id cronfa59971
recordtype SURis
fullrecord <?xml version="1.0" encoding="utf-8"?><rfc1807 xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xsd="http://www.w3.org/2001/XMLSchema"><bib-version>v2</bib-version><id>59971</id><entry>2022-05-06</entry><title>Compulsory licensing: an effective tool for securing access to Covid-19 vaccines for developing states?</title><swanseaauthors><author><sid>d956b2fe866a7d3ebbb4ca19c5e49d72</sid><ORCID>0000-0001-9870-2120</ORCID><firstname>Lowri</firstname><surname>Davies</surname><name>Lowri Davies</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2022-05-06</date><deptcode>HRCL</deptcode><abstract>A significant issue in combatting the Covid-19 pandemic is the need to enhance developing states’ access to Covid-19 vaccines. The present paper considers the request for a temporary waiver of intellectual property rights in relation to Covid-19 technologies and treatments submitted to the World Trade Organization and analyses a key argument against the proposed waiver: that the compulsory licensing provisions set out in the TRIPS Agreement are sufficiently flexible to help states get access to vaccines. The compulsory licensing flexibilities set out in TRIPS, including the amendment to TRIPS in Article 31bis, are evaluated, to explore whether compulsory licensing could be an effective tool in helping developing states to access Covid-19 vaccines. Key issues are explored from a human rights perspective to examine whether a rights-based approach to the compulsory licensing provisions could offer further insights as to how the provisions could be more workable, to enhance access to medicines and vaccines for developing states.</abstract><type>Journal Article</type><journal>Legal Studies</journal><volume>43</volume><journalNumber>1</journalNumber><paginationStart>86</paginationStart><paginationEnd>103</paginationEnd><publisher>Cambridge University Press (CUP)</publisher><placeOfPublication/><isbnPrint/><isbnElectronic/><issnPrint>0261-3875</issnPrint><issnElectronic>1748-121X</issnElectronic><keywords>Intellectual property, TRIPS, compulsory licensing, vaccines, access to medicines, human rights</keywords><publishedDay>1</publishedDay><publishedMonth>3</publishedMonth><publishedYear>2023</publishedYear><publishedDate>2023-03-01</publishedDate><doi>10.1017/lst.2022.24</doi><url>http://dx.doi.org/10.1017/lst.2022.24</url><notes/><college>COLLEGE NANME</college><department>Hillary Rodham Clinton Law School</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>HRCL</DepartmentCode><institution>Swansea University</institution><apcterm>SU Library paid the OA fee (TA Institutional Deal)</apcterm><funders>Swansea University</funders><projectreference/><lastEdited>2024-10-01T15:14:20.8623910</lastEdited><Created>2022-05-06T10:29:09.1296888</Created><path><level id="1">Faculty of Humanities and Social Sciences</level><level id="2">Hilary Rodham Clinton School of Law</level></path><authors><author><firstname>Lowri</firstname><surname>Davies</surname><orcid>0000-0001-9870-2120</orcid><order>1</order></author></authors><documents><document><filename>59971__31495__f0bccb25f0ee4b9592d6dd83731ee4df.pdf</filename><originalFilename>59971.vor.pdf</originalFilename><uploaded>2024-10-01T15:10:45.8520405</uploaded><type>Output</type><contentLength>282557</contentLength><contentType>application/pdf</contentType><version>Version of Record</version><cronfaStatus>true</cronfaStatus><documentNotes>© The Author(s), 2022. Published by Cambridge University Press on behalf of The Society of Legal Scholars. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence</documentNotes><copyrightCorrect>true</copyrightCorrect><language>eng</language><licence>https://creativecommons.org/licenses/by/4.0/</licence></document></documents><OutputDurs/></rfc1807>
spelling v2 59971 2022-05-06 Compulsory licensing: an effective tool for securing access to Covid-19 vaccines for developing states? d956b2fe866a7d3ebbb4ca19c5e49d72 0000-0001-9870-2120 Lowri Davies Lowri Davies true false 2022-05-06 HRCL A significant issue in combatting the Covid-19 pandemic is the need to enhance developing states’ access to Covid-19 vaccines. The present paper considers the request for a temporary waiver of intellectual property rights in relation to Covid-19 technologies and treatments submitted to the World Trade Organization and analyses a key argument against the proposed waiver: that the compulsory licensing provisions set out in the TRIPS Agreement are sufficiently flexible to help states get access to vaccines. The compulsory licensing flexibilities set out in TRIPS, including the amendment to TRIPS in Article 31bis, are evaluated, to explore whether compulsory licensing could be an effective tool in helping developing states to access Covid-19 vaccines. Key issues are explored from a human rights perspective to examine whether a rights-based approach to the compulsory licensing provisions could offer further insights as to how the provisions could be more workable, to enhance access to medicines and vaccines for developing states. Journal Article Legal Studies 43 1 86 103 Cambridge University Press (CUP) 0261-3875 1748-121X Intellectual property, TRIPS, compulsory licensing, vaccines, access to medicines, human rights 1 3 2023 2023-03-01 10.1017/lst.2022.24 http://dx.doi.org/10.1017/lst.2022.24 COLLEGE NANME Hillary Rodham Clinton Law School COLLEGE CODE HRCL Swansea University SU Library paid the OA fee (TA Institutional Deal) Swansea University 2024-10-01T15:14:20.8623910 2022-05-06T10:29:09.1296888 Faculty of Humanities and Social Sciences Hilary Rodham Clinton School of Law Lowri Davies 0000-0001-9870-2120 1 59971__31495__f0bccb25f0ee4b9592d6dd83731ee4df.pdf 59971.vor.pdf 2024-10-01T15:10:45.8520405 Output 282557 application/pdf Version of Record true © The Author(s), 2022. Published by Cambridge University Press on behalf of The Society of Legal Scholars. This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence true eng https://creativecommons.org/licenses/by/4.0/
title Compulsory licensing: an effective tool for securing access to Covid-19 vaccines for developing states?
spellingShingle Compulsory licensing: an effective tool for securing access to Covid-19 vaccines for developing states?
Lowri Davies
title_short Compulsory licensing: an effective tool for securing access to Covid-19 vaccines for developing states?
title_full Compulsory licensing: an effective tool for securing access to Covid-19 vaccines for developing states?
title_fullStr Compulsory licensing: an effective tool for securing access to Covid-19 vaccines for developing states?
title_full_unstemmed Compulsory licensing: an effective tool for securing access to Covid-19 vaccines for developing states?
title_sort Compulsory licensing: an effective tool for securing access to Covid-19 vaccines for developing states?
author_id_str_mv d956b2fe866a7d3ebbb4ca19c5e49d72
author_id_fullname_str_mv d956b2fe866a7d3ebbb4ca19c5e49d72_***_Lowri Davies
author Lowri Davies
author2 Lowri Davies
format Journal article
container_title Legal Studies
container_volume 43
container_issue 1
container_start_page 86
publishDate 2023
institution Swansea University
issn 0261-3875
1748-121X
doi_str_mv 10.1017/lst.2022.24
publisher Cambridge University Press (CUP)
college_str Faculty of Humanities and Social Sciences
hierarchytype
hierarchy_top_id facultyofhumanitiesandsocialsciences
hierarchy_top_title Faculty of Humanities and Social Sciences
hierarchy_parent_id facultyofhumanitiesandsocialsciences
hierarchy_parent_title Faculty of Humanities and Social Sciences
department_str Hilary Rodham Clinton School of Law{{{_:::_}}}Faculty of Humanities and Social Sciences{{{_:::_}}}Hilary Rodham Clinton School of Law
url http://dx.doi.org/10.1017/lst.2022.24
document_store_str 1
active_str 0
description A significant issue in combatting the Covid-19 pandemic is the need to enhance developing states’ access to Covid-19 vaccines. The present paper considers the request for a temporary waiver of intellectual property rights in relation to Covid-19 technologies and treatments submitted to the World Trade Organization and analyses a key argument against the proposed waiver: that the compulsory licensing provisions set out in the TRIPS Agreement are sufficiently flexible to help states get access to vaccines. The compulsory licensing flexibilities set out in TRIPS, including the amendment to TRIPS in Article 31bis, are evaluated, to explore whether compulsory licensing could be an effective tool in helping developing states to access Covid-19 vaccines. Key issues are explored from a human rights perspective to examine whether a rights-based approach to the compulsory licensing provisions could offer further insights as to how the provisions could be more workable, to enhance access to medicines and vaccines for developing states.
published_date 2023-03-01T15:14:19Z
_version_ 1811721286393528320
score 11.035634